SOURCES SOUGHT
Q -- PATIENT CONTROLLED ANALGESIC PUMP - RFI RESPONSE FORM
- Notice Date
- 11/20/2013
- Notice Type
- Sources Sought
- NAICS
- 621511
— Medical Laboratories
- Contracting Office
- Department of the Air Force, Air Force Installation Contracting (AFICA), Air Force Installation Contracting (AFICA), 1940 Allbrook Dr, Bldg 1, Door 1, Room 300, Cubicle 481, Wright Patterson AFB, Ohio, 45433-5344, United States
- ZIP Code
- 45433-5344
- Solicitation Number
- AFICA_AFMESA-14-RFI_PATIENT_CONTROLLED_ANALGESIC_PUMP
- Archive Date
- 1/3/2014
- Point of Contact
- Ashley Fredlock, Phone: 301-619-8600
- E-Mail Address
-
AFMSA.SG5T.Market@us.af.mil
(AFMSA.SG5T.Market@us.af.mil)
- Small Business Set-Aside
- N/A
- Description
- PCA_RFI RESPONSE FORM THIS IS NOT A REQUEST FOR PROPOSALS OR A REQUEST FOR QUOTATIONS; IT IS STRICTLY A REQUEST FOR INFORMATION (RFI). NEITHER UNSOLICITED PROPOSALS NOR ANY OTHER KINDS OF OFFERS WILL BE CONSIDERED IN RESPONSE TO THIS RFI. NO CONTRACT WILL BE AWARDED PURSUANT TO THIS ANNOUNCEMENT. 1. SUBJECT: The Air Force Medical Evaluation Support Activity (AFMESA) is conducting market research on transport patient controlled analgesic pumps (PCA) suitable for use in patient care in the military expeditionary medical environment. Responses are due to this request for information (RFI) by 2:00 P.M. (EST) on 19 December 2013. 2. DISCLAIMER: This RFI is issued solely for information and planning purposes and does not constitute a solicitation. Neither unsolicited proposals nor any other kind of offers will be considered in response to this RFI. Responses to this notice are not offers and will not be accepted by the Government to form a binding contract. Respondents are solely responsible for all expenses associated with responding to this RFI. All information received in response to this RFI marked as "proprietary" will be handled accordingly. Information provided as a response to the RFI will not be returned. AFMESA will not entertain any questions concerning the composition, requirements, or the nature of services to be performed under any future request for proposal (RFP). 3. BACKGROUND: Patients are transported in the military expeditionary medical environment with the need for pain management. Currently, the Air Force utilizes a PCA pump as one mechanism to accomplish pain management in transport. The Air Mobility Command (AMC) is collecting information on new transport PCAs to meet this need. The PCA must be safe and suitable to operate in the unique constraints of the military expeditionary medical environment. AMC prefers commercial off-the-shelf (COTS) items but will accept information on government off-the-shelf (GOTS) and foreign off-the-shelf (FOTS) products as well as research and development (R&D) options. 4. REQUIREMENTS: The PCA sought must operate in an austere environment with the ability to easily and safely transition with the patient throughout the continuum of care. Responses should address the requirements identified in this RFI, particularly those outlined in 4A below. 4A. MANDATORY REQUIREMENTS: The candidate PCA pump must satisfy the following requirements: 1. Device should be "approved for market" (PMA), "cleared to market" (510k), or "legally marketed" (as defined in the Code of Federal Regulations - 21 CFR807.92(a)(3) for class I and II devices). 2. Device should be able to meet all DOD Air Worthiness Certification (AWC), Joint En Route Care Equipment Test Standard (JECETS), and Military Standard 810G Environmental Engineering Considerations and Laboratory Tests (MIL-STD-810G). 3. The PCA pump must be transportable by an ambulatory patient via a carrying container or other mechanism and must be capable of mounting securely to existing transport devices for litter or wheelchair patients. 4. The PCA pump must weigh less than 3 lbs (1.4 kilograms). 5. The PCA pump must be capable of delivering continuous (basal) and/or dosed IV medications with or without using a patient controlled mechanism (e.g., button or other demand mechanism). 6. The PCA pump must operate continuously on battery power for at least 8 hours. 7. The PCA pump must be capable of using common disposable batteries (i.e., size AAA, AA, C, or D) or rechargeable batteries that utilize 110 VAC power, 50-60 Hz. 8. Batteries must be contained within the PCA pump and conform to the transport and weight constraints above. 9. Narcotic medications must be locked (to prevent tampering). Pump programming must be capable of preventing the patient from changing the program. 10. The PCA pump must operate in an environment 32 °F through 140 °F for 2 hours (T), 4 hours (O).* 11. The PCA pump must be capable of long-term storage in a facility that is not environmentally controlled (e.g., -40 °F through 140 °F) 12. The PCA pump must be capable of operation and storage in environments with humidity levels of 0 to 90 percent. 13. Pump must maintain a 48-hour history with the ability to query reports for shorter time frames without losing the 48-hour history. 14. Pump must have a mechanism for the user to collect and transfer historical information on use, medication, amounts, and timeframes. 15. Pump must have audible and visual alarms (T) and haptic alarms (O).* 16. Pump must have a lock out for patient controlled mechanism. If the dosage maximum is reached the pump will not activate. 17. Pump must be equipped with a customizable on-board drug library and be equipped with drug calculation software (i.e., concentration of medication equals mg delivered over time). 18. Pump should not use proprietary consumables. 19. Medication should be able to be locked inside or onto the pump. 20. The button/mechanism used by the patient to trigger medication delivery SHOULD NOT be part of the programming/clearing/review function of the device. *A requirement normally has a threshold (T), representing the required value, and an objective (O), representing the desired value. 5. RESPONSE INFORMATION: Response to this RFI must be submitted to Ms. Ashley A. Fredlock, Market Research Analyst, via e-mail to AFMSA.SG5T.Market@us.af.mil. Email responses should be no larger than 10 MB in size. If larger attachments are required, please notify AFMESA at the above listed email address. Each RFI response will receive a confirmation email; if a confirmation is not received please call 301-619-8600. Please include a point of contact, phone number, e-mail address, website information, and indicate whether the company is a foreign or domestic entity in the contents of the e-mail. Responses must be received by this office on or before 2:00 P.M. (EST) on 19 December 2013. This RFI is not a commercial solicitation. The Government will not pay for any information submitted, or for any costs associated with providing the information. The response should describe the company's capability to offer, field, and sustain the PCA as characterized by the requirements addressed in this RFI. If unable to provide a PCA capable of meeting all requirements, the respondent should offer tradeoff considerations. 6. LATE SUBMISSIONS: Failure to respond to this RFI does not preclude participation in any future competition, nor will information provided in response to this RFI be used to exclude anyone from responding to any future requests for proposals. Communications with AFMESA in regard to this RFI will only be permitted in writing during the RFI response period. Responses to the RFI received by AFMESA after the submittal deadline and time indicated may be considered. The respondent assumes the risk of the method of dispatch chosen. Postmarking by the submittal date and time shall not substitute for actual response receipt. 7. OWNERSHIP OF RESPONSE TO RFI: All informational material submitted in response to this request becomes property of AFMESA. Physical samples will be returned to the vendor at the owner's expense. 8. RELEASE OF CLAIMS, LIABILITY, AND PREPARATION EXPENSES: Under no circumstances shall AFMESA be responsible for any response preparation expenses, submission costs, or any other expenses, costs, or damages of whatever nature incurred as a result of the respondent's participation in this RFI process. Respondent understands and agrees that they submit a response at their own risk and expense, and release AFMESA from any claim for damages or other liability arising out of the RFI process. 9. ERRORS IN RESPONSE: AFMESA shall not be liable for any errors in respondent's response. Respondent is responsible for careful review of its entire response to ensure that all information is correct and complete. Respondents are liable for all errors or omissions contained in their responses. 10. ADDENDUM: AFMESA reserves the right to issue an addendum to this RFI at any time for any reason. 11. CONTACT INFORMATION: Ms. Ashley A. Fredlock Air Force Medical Evaluation Support Activity (AFMESA) 1270 Montevue Lane (Area B) Fort Detrick, MD 21702 Phone: 301-619-8600 AFMSA.SG5T.Market@us.af.mil
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/notices/9280d0480fd2e24fb20bfdfc17c44469)
- Place of Performance
- Address: Air Force Medical Evaluation Support Activity (AFMESA), 1270 Montevue Lane (Area B), Fort Detrick, MD 21702, Fort Dietrick, Maryland, 21702, United States
- Zip Code: 21702
- Zip Code: 21702
- Record
- SN03238154-W 20131122/131120234818-9280d0480fd2e24fb20bfdfc17c44469 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |